The presence of blood in the urine is called hematuria. Kidney stones, urinary tract infections and hereditary diseases are some of the leading causes of hematuria. The urine does not contain red blood cells, and the presence of blood in urine can lead to a serious problem that can also cause kidney stones, urinary tract infections, and other hereditary diseases. The causes of blood in the urine are infections of the bladder, kidney or prostate, vigorous exercise, viral diseases such as hepatitis A virus, which causes liver disease and inflammation of the liver. More serious reasons that cause hematuria include bladder or kidney cancer, inflammation of the kidneys, urethra, bladder, or prostate. Increasing scope for the treatment is expected to offer significant growth opportunities to the hematuria treatment market in the forecast period.
MARKET DYNAMIC- UNITED STATES HEMATURIA TREATMENT MARKET
The major factors driving the growth of the market is increasing geriatric population that is more susceptible to develop hematuria disease due to rising prevalence of urinary tract infection, kidney stone are some of the major reasons of hematuria among adults which is contributing to the growth of the market in the country. Also technological developments in medical devices and diagnostic procedures have led to various options for managing hematuria-associated indications such as kidney stones, bladder stones, and urinary tract infections are propelling the hematuria treatment market growth. The use of advanced treatment technologies and the continuous support from the U.S. government will offer lucrative growth opportunities in the country.
COVID-19 IMPACT ON UNITED STATES HEMATURIA TREATMENT MARKET REPORT
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the United States hematuria treatment market. In addition, complete analysis of changes on the United States hematuria treatment market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on United States economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 outbreak has substantially affected the incidence and management of kidney diseases including acute kidney injury (AKI), end-stage kidney disease, glomerulonephritis, and kidney transplantation. That positively contributes to the growth of the hematuria treatment market in the country.
Get Request For Free Sample Report :- https://www.axiommrc.com/request-for-sample/11187-united-states-hematuria-treatment-market-report
UNITED STATES HEMATURIA TREATMENT MARKET- SEGMENTAL OVERVIEW
The hematuria treatment market comprises of different market segment like type, indication, treatment and end user.
UNITED STATES HEMATURIA TREATMENT MARKET BY TYPE
The hematuria treatment is available in market according different type including macroscopic hematuria, microscopic hematuria, idiopathic hematuria, jogger’s hematuria. Macroscopic is visible blood in the urine where the urine appears pink, red, reddish-brown, or tea-colored. With microscopic hematuria, there is no visual evidence of the presence of blood unless the urine is examined under a microscope. In case of idiopathic hematuria there is no specific cause for the appearance of blood in the urine, and a family history of no kidney disease does not require specific treatment for idiopathic hematuria. The jogger’s hematuria most commonly occur in athletes due to hard training and rigorous exercise and the hematuria can range from serious to harmless in case of severity.
UNITED STATES HEMATURIA TREATMENT MARKET BY INDICATION
The hematuria treatment market has different indication like urinary tract infections, kidney stones, urethritis, blood cancer, bladder stones, prostate cancer, cystitis, trauma, vigorous exercise, polycystic kidney disease, endometriosis, menstruation. Urinary tract infections are often caused by microorganisms, usually bacteria that invade the urethra and bladder and cause inflammation and infection. Urinary tract infections are most common in the urethra and bladder, but bacteria can travel up the ureters and infect the kidneys. Excessive level of calcium in the urine can cause kidney stones even people with a family history of kidney stones are more prone to kidney stones, which gradually lead to hematuria. In case if idiopathic hematuria which is commonly known as exercise hematuria which is a harmless condition that produces blood in the urine after strenuous exercise also it is more common in males than females.
UNITED STATES HEMATURIA TREATMENT MARKET BY TREATMENT
The hematuria treatment market includes different treatments such as drugs, therapies. The healthcare professionals diagnose hematuria and its causes with a medical history, physical exam, urinalysis, and some additional tests. Adults diagnosed with microscopic hematuria with normal blood pressure and kidney function are recommended to undergo multiple urine tests over several months if still the presence of bold continues a kidney ultrasound may be performed. Treatment for hematuria depends on the following tests and the type of hematuria detected. In the absence of a family history of kidney disease, specific treatment to manage hematuria is not required. Hematuria in severe infection is due to kidney or bladder cancer, polycystic kidney disease, sickle cell anemia, or a family history of kidney disease that requires multiple tests to find the cause and advance treatment to cure hematuria. Even in some cases, antibiotic treatment is enough to treat the disease.
UNITED STATES HEMATURIA TREATMENT MARKET BY END USER
The hematuria treatment market finds its major end user in hospitals, clinics, ambulatory surgical centers, others. The treatment depends on the cause of the blood in your urine. To find out the cause, your doctor may ask about your family history and test your urine. A lab will test the urine sample for signs of an infection, kidney disease or other problems. Many patients with serious infection require dialysis multiple times a week in healthcare facilities. The incidence and management of kidney diseases, including acute kidney injury, end-stage kidney disease, glomerulonephritis, and kidney transplantation also due to the higher prevalence of comorbidities such as hypertension, diabetes, and chronic kidney disease that requires hospitalization has boosted the growth of the hospital segment.
UNITED STATES HEMATURIA TREATMENT MARKET KEY PLAYER
The key players in hematuria treatment market are AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd, Boehringer Ingelheim International GmbH and The Medicines Company among others.
Request For Best Pricing :- https://www.axiommrc.com/request-for-sample/11187-united-states-hematuria-treatment-market-report
About Us:
Axiom Market Research Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc. Axiom Market Research Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.Axiom MRC with its experienced team of research and data analysts, has delivered more than 5000+ Market Research Projects, 3800+ Data Analytics Projects, 1200+ Business Support Projects and has a 800+ Global Client Base. Axiom Market Research Consulting™ aims to become the preferred market research and data Analytics Company by providing key market intelligence solutions for client’s business growth.
Contact Us:
Axiom Market Research Consulting™
3 Germay Dr. Ste 4 - 4666
Wilmington DE 19804
U.S.:- + 1 (845) 875-9786
U.K.:- + 44 (0) 20 3286 9707
Email: [email protected]
Website: https://www.axiommrc.com/
Follow On
LinkedIn: https://www.linkedin.com/company/axiom-market-research-and-consulting/
Twitter: https://twitter.com/AxiommrcCom
